Hoping for trouble
Hoping for trouble
Leading venture firm Kleiner Perkins Caulfield & Byers is launching a $200 million Pandemic and Bio Defense Fund to invest in surveillance and disease detection, diagnosis, vaccines, and anti-viral drugs. The terrorists are quaking in their boots now that investors are involved.
Leading venture firm Kleiner Perkins Caulfield & Byers is launching a $200 million Pandemic and Bio Defense Fund to invest in surveillance and disease detection, diagnosis, vaccines, and anti-viral drugs. The terrorists are quaking in their boots now that investors are involved.
1 Comments:
Investors, consultants, epidemiologists, social workers? Now that's what I call a fantastic four!
Post a Comment
<< Home